PCI Biotech Holding ASA (LON:0JGL)
London · Delayed Price · Currency is GBP · Price in NOK 0.2470
+0.0090 (3.78%)
Feb 11, 2026, 11:06 AM GMT
PCI Biotech Holding ASA Market Cap
PCI Biotech Holding ASA has a market cap or net worth of 658.16 thousand as of February 12, 2026. Its market cap has decreased by -80.09% in one year.
Market Cap
658.16K
Enterprise Value
-368.61K
Revenue
338.24K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.25
Market Cap Chart
Since June 23, 2008, PCI Biotech Holding ASA's market cap has decreased from 9.62M to 658.16K, a decrease of -93.16%. That is a compound annual growth rate of -14.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 683.62K | 0.67% |
| Dec 30, 2025 | 679.07K | -78.21% |
| Dec 30, 2024 | 3.12M | -48.53% |
| Dec 29, 2023 | 6.05M | -6.08% |
| Dec 30, 2022 | 6.45M | -85.24% |
| Dec 30, 2021 | 43.67M | -51.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 231.18B |
| GSK plc | 85.92B |
| Haleon | 36.22B |
| Smith & Nephew | 11.10B |
| Chill Brands Group | 2.35M |
| BSF Enterprise | 2.31M |
| Roquefort Therapeutics | 1.80M |
| Physiomics | 1.52M |